---
title: 'Current Progress in Vaccines against Merkel Cell Carcinoma: A Narrative Review
  and Update'
date: '2024-05-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38793784/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240526182247&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Merkel cell carcinoma is a rare, aggressive skin cancer that mainly occurs
  in elderly and immunocompromised patients. Due to the success of immune checkpoint
  inhibition in MCC, the importance of immunotherapy and vaccines in MCC has increased
  in recent years. In this article, we aim to present the current progress and perspectives
  in the development of vaccines for this disease. Here, we summarize and discuss
  the current literature and ongoing clinical trials investigating vaccines against
  ...
disable_comments: true
---
Merkel cell carcinoma is a rare, aggressive skin cancer that mainly occurs in elderly and immunocompromised patients. Due to the success of immune checkpoint inhibition in MCC, the importance of immunotherapy and vaccines in MCC has increased in recent years. In this article, we aim to present the current progress and perspectives in the development of vaccines for this disease. Here, we summarize and discuss the current literature and ongoing clinical trials investigating vaccines against ...